A proteomic analysis of human gastric cancer cells treated with erinacine A revealed notable shifts in protein expression, marked by the upregulation of tumor suppressors 14-3-3σ (1433S) and MTUS2, and a reduction in nucleophosmin (NPM). Here, MTUS2 is linked to gastric cancer.